针对免疫细胞向和免疫调节的mRNA-脂质纳米粒子工程的进展
Cheesue Kim1,2, Yeji Lee3, Hyukjin Lee3,4
1Institute of Chemical Processes, Seoul National University, Seoul, 08826, Republic of Korea.
Small methods
|September 17, 2025
概括
通过脂质纳米粒子 (LNP) 传递的基于信使RNA (mRNA) 的疗法,为免疫疗法提供了一种强大的新方法. 这些mRNA-LNP增强蛋白质合成和免疫细胞重编程,用于治疗各种疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 分子生物学分子生物学
背景情况:
- 使用抗体,细胞因子和基于细胞的策略的免疫疗法彻底改变了瘤学,并扩展到纤维化,自身免疫和传染性疾病.
- 传递 RNA (mRNA) 平台能够在体内合成原生修饰的蛋白质,改善生物活性并降低免疫性.
- mRNA允许短暂的免疫细胞重编程,没有插入突变发生的风险,促进可扩展的制造.
研究的目的:
- 审查工程mRNA-脂质纳米颗粒 (LNPs) 的进步,以针对性地传递免疫细胞.
- 探索使用mRNA-LNP进行细胞类型特异性免疫调节的策略.
- 讨论mRNA-LNP免疫疗法在各种免疫相关病理中的应用.
主要方法:
- 在脂质纳米颗粒 (LNP) 中封装mRNA,以克服裸体mRNA传递的挑战.
- 工程 mRNA-LNP 保护,有效地传递到目标免疫细胞.
- 通过mRNA-LNP研究免疫细胞功能的细胞类型特异调节.
主要成果:
- 临床核蛋白保护mRNA免受降解,并改善细胞吸收和向传递.
- mRNA-LNP显示出精确调节免疫细胞功能的潜力.
- 在mRNA-LNP工程方面的进步提高了传递效率和免疫学结果.
结论:
- mRNA-LNP代表了一种有前途的平台,用于跨疾病的先进免疫疗法.
- 有针对性的输送和细胞特异性调制是最大限度地发挥mRNA-LNP治疗潜力的关键.
- 进一步的设计考虑对于mRNA-LNP免疫疗法的临床转化至关重要.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.


